| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Satsuma Pharmaceuticals Inc (NASDAQ: STSA)
STSA Technical Analysis
5
| As on 7th Jun 2023 STSA SHARE Price closed @ 1.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.55 & Strong Sell for SHORT-TERM with Stoploss of 4.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
STSASHARE Price
| Open | 1.11 | Change | Price | % |
| High | 1.14 | 1 Day | -0.01 | -0.90 |
| Low | 1.01 | 1 Week | 0.04 | 3.77 |
| Close | 1.10 | 1 Month | 0.05 | 4.76 |
| Volume | 1829701 | 1 Year | -3.57 | -76.45 |
| 52 Week High 7.95 | 52 Week Low 0.61 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| STSA Daily Charts |
STSA Intraday Charts |
Whats New @ Bazaartrend |
STSA Free Analysis |
|
|
STSA Important Levels Intraday
| RESISTANCE | 1.35 |
| RESISTANCE | 1.27 |
| RESISTANCE | 1.22 |
| RESISTANCE | 1.17 |
| SUPPORT | 1.03 |
| SUPPORT | 0.98 |
| SUPPORT | 0.93 |
| SUPPORT | 0.85 |
STSA Forecast April 2024
| 4th UP Forecast | 3.64 |
| 3rd UP Forecast | 2.83 |
| 2nd UP Forecast | 2.32 |
| 1st UP Forecast | 1.82 |
| 1st DOWN Forecast | 0.38 |
| 2nd DOWN Forecast | -0.12 |
| 3rd DOWN Forecast | -0.63 |
| 4th DOWN Forecast | -1.44 |
STSA Weekly Forecast
| 4th UP Forecast | 2.10 |
| 3rd UP Forecast | 1.78 |
| 2nd UP Forecast | 1.58 |
| 1st UP Forecast | 1.38 |
| 1st DOWN Forecast | 0.82 |
| 2nd DOWN Forecast | 0.62 |
| 3rd DOWN Forecast | 0.42 |
| 4th DOWN Forecast | 0.10 |
STSA Forecast2024
| 4th UP Forecast | 15.53 |
| 3rd UP Forecast | 10.9 |
| 2nd UP Forecast | 8.04 |
| 1st UP Forecast | 5.18 |
| 1st DOWN Forecast | -2.98 |
| 2nd DOWN Forecast | -5.84 |
| 3rd DOWN Forecast | -8.7 |
| 4th DOWN Forecast | -13.33 |
Satsuma Pharmaceuticals Inc ( NASDAQ USA Symbol : STSA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
STSA Business Profile
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. Its lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in ASCEND Phase III clinical trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. The company was incorporated in 2016 and is headquartered in South San Francisco, California. Address: 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service